Brandon R Macias1, Nimesh B Patel2, C Robert Gibson3, Brian C Samuels4, Steven S Laurie1, Christian Otto5, Connor R Ferguson6, Stuart M C Lee1, Robert Ploutz-Snyder7, Larry A Kramer8, Thomas H Mader9, Tyson Brunstetter10, Michael B Stenger11. 1. KBR, Houston, Texas. 2. University of Houston College of Optometry, Houston, Texas. 3. Coastal Eye Associates, Webster, Texas. 4. Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham. 5. Memorial Sloan Kettering Cancer Center, New York, New York. 6. MEI Technologies, Houston, Texas. 7. Department of Systems, Populations and Leadership, University of Michigan, Ann Arbor. 8. Department of Diagnostic and Interventional Imaging, University of Texas Health Science Center, Houston. 9. US Army, Moab, Utah. 10. US Navy detailed to NASA (National Aeronautics and Space Administration) Johnson Space Center, Houston, Texas. 11. NASA Johnson Space Center, Houston, Texas.
Abstract
Importance: During long-duration spaceflights, nearly all astronauts exhibit some change in ocular structure within the spectrum of spaceflight-associated neuro-ocular syndrome. Objective: To quantitatively determine in a prospective study whether changes in ocular structures hypothesized to be associated with the development of spaceflight-associated neuro-ocular syndrome occur during 6-month missions on board the International Space Station (ISS). Design, Setting, and Participants: The Ocular Health ISS Study of astronauts is a longitudinal prospective cohort study that uses objective quantitative imaging modalities. The present cohort study investigated the ocular structure of 11 astronauts before, during, and after a 6-month mission on board the ISS. Main Outcomes and Measures: Changes in ocular structure (peripapillary edema, axial length, anterior chamber depth, and refraction) hypothesized to be associated with the development of spaceflight-associated neuro-ocular syndrome during 6-month missions on board the ISS were assessed. Statistical analyses were conducted from August 2018 to January 2019. Results: Before launch, the 11 astronauts were a mean (SD) age of 45 (5) years, a mean (SD) height of 1.76 (0.05) m, and a mean (SD) weight of 75.3 (7.1) kg. Six astronauts did not have prior spaceflight experience, 3 had completed short-duration missions on board the Space Shuttle, and 2 had previous long-duration spaceflight missions on board the ISS. Their mean (SD) duration on board the ISS in the present study was 170 (19) days. Optic nerve head rim tissue and peripapillary choroidal thickness increased from preflight values during early spaceflight, with maximal change typically near the end of the mission (mean change in optic nerve head rim tissue thickness on flight day 150: 35.7 μm; 95% CI, 28.5-42.9 μm; P < .001; mean choroidal thickness change on flight day 150: 43 μm; 95% CI, 35-46 μm; P < .001). The mean postflight axial length of the eye decreased by 0.08 mm (95% CI, 0.10-0.07 mm; P < .001) compared with preflight measures, and this change persisted through the last examination (1 year after spaceflight: 0.05 mm; 95% CI, 0.07-0.03 mm; P < .001). Conclusions and Relevance: This study found that spaceflight-associated peripapillary optic disc edema and choroid thickening were observed bilaterally and occurred in both sexes. In addition, this study documented substantial peripapillary choroid thickening during spaceflight, which has never been reported in a prospective study cohort population and which may be a contributing factor in spaceflight-associated neuro-ocular syndrome. Data collection on spaceflight missions longer than 6 months will help determine whether the duration of the mission is associated with exacerbating these observed changes in ocular structure or visual function.
Importance: During long-duration spaceflights, nearly all astronauts exhibit some change in ocular structure within the spectrum of spaceflight-associated neuro-ocular syndrome. Objective: To quantitatively determine in a prospective study whether changes in ocular structures hypothesized to be associated with the development of spaceflight-associated neuro-ocular syndrome occur during 6-month missions on board the International Space Station (ISS). Design, Setting, and Participants: The Ocular Health ISS Study of astronauts is a longitudinal prospective cohort study that uses objective quantitative imaging modalities. The present cohort study investigated the ocular structure of 11 astronauts before, during, and after a 6-month mission on board the ISS. Main Outcomes and Measures: Changes in ocular structure (peripapillary edema, axial length, anterior chamber depth, and refraction) hypothesized to be associated with the development of spaceflight-associated neuro-ocular syndrome during 6-month missions on board the ISS were assessed. Statistical analyses were conducted from August 2018 to January 2019. Results: Before launch, the 11 astronauts were a mean (SD) age of 45 (5) years, a mean (SD) height of 1.76 (0.05) m, and a mean (SD) weight of 75.3 (7.1) kg. Six astronauts did not have prior spaceflight experience, 3 had completed short-duration missions on board the Space Shuttle, and 2 had previous long-duration spaceflight missions on board the ISS. Their mean (SD) duration on board the ISS in the present study was 170 (19) days. Optic nerve head rim tissue and peripapillary choroidal thickness increased from preflight values during early spaceflight, with maximal change typically near the end of the mission (mean change in optic nerve head rim tissue thickness on flight day 150: 35.7 μm; 95% CI, 28.5-42.9 μm; P < .001; mean choroidal thickness change on flight day 150: 43 μm; 95% CI, 35-46 μm; P < .001). The mean postflight axial length of the eye decreased by 0.08 mm (95% CI, 0.10-0.07 mm; P < .001) compared with preflight measures, and this change persisted through the last examination (1 year after spaceflight: 0.05 mm; 95% CI, 0.07-0.03 mm; P < .001). Conclusions and Relevance: This study found that spaceflight-associated peripapillary optic disc edema and choroid thickening were observed bilaterally and occurred in both sexes. In addition, this study documented substantial peripapillary choroid thickening during spaceflight, which has never been reported in a prospective study cohort population and which may be a contributing factor in spaceflight-associated neuro-ocular syndrome. Data collection on spaceflight missions longer than 6 months will help determine whether the duration of the mission is associated with exacerbating these observed changes in ocular structure or visual function.
Authors: Thomas H Mader; C Robert Gibson; Anastas F Pass; Larry A Kramer; Andrew G Lee; Jennifer Fogarty; William J Tarver; Joseph P Dervay; Douglas R Hamilton; Ashot Sargsyan; John L Phillips; Duc Tran; William Lipsky; Jung Choi; Claudia Stern; Raffi Kuyumjian; James D Polk Journal: Ophthalmology Date: 2011-08-17 Impact factor: 12.079
Authors: Justin S Lawley; Lonnie G Petersen; Erin J Howden; Satyam Sarma; William K Cornwell; Rong Zhang; Louis A Whitworth; Michael A Williams; Benjamin D Levine Journal: J Physiol Date: 2017-02-14 Impact factor: 5.182
Authors: Andrew J Feola; Emily S Nelson; Jerry Myers; C Ross Ethier; Brian C Samuels Journal: Invest Ophthalmol Vis Sci Date: 2018-08-01 Impact factor: 4.799
Authors: Thomas H Mader; C Robert Gibson; Christian A Otto; Ashot E Sargsyan; Neil R Miller; Prem S Subramanian; Stephen F Hart; William Lipsky; Nimesh B Patel; Andrew G Lee Journal: J Neuroophthalmol Date: 2017-06 Impact factor: 3.042
Authors: Jennifer Law; Mary Van Baalen; Millennia Foy; Sara S Mason; Claudia Mendez; Mary L Wear; Valerie E Meyers; David Alexander Journal: J Occup Environ Med Date: 2014-05 Impact factor: 2.162
Authors: Patrick A Sibony; Mark J Kupersmith; Steven E Feldon; Jui-Kai Wang; Mona Garvin Journal: Invest Ophthalmol Vis Sci Date: 2015-09 Impact factor: 4.799
Authors: Karina Marshall-Goebel; Steven S Laurie; Irina V Alferova; Philippe Arbeille; Serena M Auñón-Chancellor; Douglas J Ebert; Stuart M C Lee; Brandon R Macias; David S Martin; James M Pattarini; Robert Ploutz-Snyder; L Christine Ribeiro; William J Tarver; Scott A Dulchavsky; Alan R Hargens; Michael B Stenger Journal: JAMA Netw Open Date: 2019-11-01
Authors: Jessica V Jasien; Steven S Laurie; Stuart M C Lee; David S Martin; David T Kemp; Douglas J Ebert; Robert Ploutz-Snyder; Karina Marshall-Goebel; Irina V Alferova; Ashot Sargsyan; Richard W Danielson; Alan R Hargens; Scott A Dulchavsky; Michael B Stenger; Brandon R Macias Journal: J Appl Physiol (1985) Date: 2022-07-21
Authors: Stuart H Sater; Austin M Sass; Akari Seiner; Gabryel Conley Natividad; Dev Shrestha; Audrey Q Fu; John N Oshinski; C Ross Ethier; Bryn A Martin Journal: J R Soc Interface Date: 2021-04-28 Impact factor: 4.293
Authors: Ruchi J Vyas; Millennia Young; Matthew C Murray; Marina Predovic; Shiyin Lim; Nicole M Jacobs; Sara S Mason; Susana B Zanello; Giovanni Taibbi; Gianmarco Vizzeri; Patricia Parsons-Wingerter Journal: Invest Ophthalmol Vis Sci Date: 2020-12-01 Impact factor: 4.799
Authors: Stuart M C Lee; David S Martin; Christopher A Miller; Jessica M Scott; Steven S Laurie; Brandon R Macias; Nathaniel D Mercaldo; Lori Ploutz-Snyder; Michael B Stenger Journal: Front Physiol Date: 2020-07-28 Impact factor: 4.566
Authors: Jesse J Rohr; Stuart Sater; Austin M Sass; Karina Marshall-Goebel; Robert J Ploutz-Snyder; C Ross Ethier; Michael B Stenger; Bryn A Martin; Brandon R Macias Journal: NPJ Microgravity Date: 2020-10-08 Impact factor: 4.415
Authors: Steven S Laurie; Scott H Greenwald; Karina Marshall-Goebel; Laura P Pardon; Akash Gupta; Stuart M C Lee; Claudia Stern; Haleh Sangi-Haghpeykar; Brandon R Macias; Eric M Bershad Journal: Physiol Rep Date: 2021-08